Viewing Study NCT04311957


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-05 @ 5:47 PM
Study NCT ID: NCT04311957
Status: UNKNOWN
Last Update Posted: 2020-08-03
First Post: 2020-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Sponsor: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module